Loading…
Participation of ATP-sensitive K+ channels in the peripheral antinociceptive effect of fentanyl in rats
We examined the effect of several K+ channel blockers such as glibenclamide, tolbutamide, charybdotoxin (ChTX), apamin, tetraethylammonium chloride (TEA), 4-aminopyridine (4-AP), and cesium on the ability of fentanyl, a clinically used selective micro-opioid receptor agonist, to promote peripheral a...
Saved in:
Published in: | Brazilian journal of medical and biological research 2005-01, Vol.38 (1), p.91-97 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c465t-3d6d9c2288cbb69d314dd1a556040fe6b53e8b7d5d2cddfa983471a935a6e0703 |
---|---|
cites | cdi_FETCH-LOGICAL-c465t-3d6d9c2288cbb69d314dd1a556040fe6b53e8b7d5d2cddfa983471a935a6e0703 |
container_end_page | 97 |
container_issue | 1 |
container_start_page | 91 |
container_title | Brazilian journal of medical and biological research |
container_volume | 38 |
creator | Rodrigues, A R A Castro, M S A Francischi, J N Perez, A C Duarte, I D G |
description | We examined the effect of several K+ channel blockers such as glibenclamide, tolbutamide, charybdotoxin (ChTX), apamin, tetraethylammonium chloride (TEA), 4-aminopyridine (4-AP), and cesium on the ability of fentanyl, a clinically used selective micro-opioid receptor agonist, to promote peripheral antinociception. Antinociception was measured by the paw pressure test in male Wistar rats weighing 180-250 g (N = 5 animals per group). Carrageenan (250 microg/paw) decreased the threshold of responsiveness to noxious pressure (delta = 188.1 +/- 5.3 g). This mechanical hyperalgesia was reduced by fentanyl (0.5, 1.5 and 3 microg/paw) in a peripherally mediated and dose-dependent fashion (17.3, 45.3 and 62.6%, respectively). The selective blockers of ATP-sensitive K+ channels glibenclamide (40, 80 and 160 microg/paw) and tolbutamide (80, 160 and 240 microg/paw) dose dependently antagonized the antinociception induced by fentanyl (1.5 microg/paw). In contrast, the effect of fentanyl was unaffected by the large conductance Ca2+-activated K+ channel blocker ChTX (2 microg/paw), the small conductance Ca2+-activated K+ channel blocker apamin (10 microg/paw), or the non-specific K+ channel blocker TEA (150 microg/paw), 4-AP (50 microg/paw), and cesium (250 microg/paw). These results extend previously reported data on the peripheral analgesic effect of morphine and fentanyl, suggesting for the first time that the peripheral micro-opioid receptor-mediated antinociceptive effect of fentanyl depends on activation of ATP-sensitive, but not other, K+ channels. |
doi_str_mv | 10.1590/S0100-879X2005000100014 |
format | article |
fullrecord | <record><control><sourceid>scielo_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_54b3541719c443888efde4ee8c775e07</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><scielo_id>S0100_879X2005000100014</scielo_id><doaj_id>oai_doaj_org_article_54b3541719c443888efde4ee8c775e07</doaj_id><sourcerecordid>S0100_879X2005000100014</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-3d6d9c2288cbb69d314dd1a556040fe6b53e8b7d5d2cddfa983471a935a6e0703</originalsourceid><addsrcrecordid>eNp9kVtLHTEQgIMo9da_YPdd1k42yW7yKNKqVFCoBd9CNpl4cliTJYkF_73nIioU-pRkJt_HXAj5RuGMCgXffwMFaOWgHjoAAbB-AuU75OA9sfvpvk8OS1kCdAI4_UL2qeh7oRQ_II93Jtdgw2xqSLFJvjm_v2sLxhJq-IvNr9PGLkyMOJUmxKYusJkxh3mB2UyNiTXEZIPFefMbvUdb1xaPsZr4Mq2hbGo5JnveTAW_vp1H5M_PH_cXV-3N7eX1xflNa3kvastc75TtOintOPbKMcqdo0aIHjh47EfBUI6DE66zznmjJOMDNYoJ0yMMwI7I9dbrklnqOYcnk190MkFvAik_6k3DE2rBRyY4HaiynDMpJXqHHFHaYRAr2cp1tnUVG3BKepmec1wVrzfT1_9MfwUMW8DmVEpG_14ABb3e23_Iky05P49P6D64t0WxV6z2kW4</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Participation of ATP-sensitive K+ channels in the peripheral antinociceptive effect of fentanyl in rats</title><source>IngentaConnect Journals</source><source>SciELO</source><creator>Rodrigues, A R A ; Castro, M S A ; Francischi, J N ; Perez, A C ; Duarte, I D G</creator><creatorcontrib>Rodrigues, A R A ; Castro, M S A ; Francischi, J N ; Perez, A C ; Duarte, I D G</creatorcontrib><description>We examined the effect of several K+ channel blockers such as glibenclamide, tolbutamide, charybdotoxin (ChTX), apamin, tetraethylammonium chloride (TEA), 4-aminopyridine (4-AP), and cesium on the ability of fentanyl, a clinically used selective micro-opioid receptor agonist, to promote peripheral antinociception. Antinociception was measured by the paw pressure test in male Wistar rats weighing 180-250 g (N = 5 animals per group). Carrageenan (250 microg/paw) decreased the threshold of responsiveness to noxious pressure (delta = 188.1 +/- 5.3 g). This mechanical hyperalgesia was reduced by fentanyl (0.5, 1.5 and 3 microg/paw) in a peripherally mediated and dose-dependent fashion (17.3, 45.3 and 62.6%, respectively). The selective blockers of ATP-sensitive K+ channels glibenclamide (40, 80 and 160 microg/paw) and tolbutamide (80, 160 and 240 microg/paw) dose dependently antagonized the antinociception induced by fentanyl (1.5 microg/paw). In contrast, the effect of fentanyl was unaffected by the large conductance Ca2+-activated K+ channel blocker ChTX (2 microg/paw), the small conductance Ca2+-activated K+ channel blocker apamin (10 microg/paw), or the non-specific K+ channel blocker TEA (150 microg/paw), 4-AP (50 microg/paw), and cesium (250 microg/paw). These results extend previously reported data on the peripheral analgesic effect of morphine and fentanyl, suggesting for the first time that the peripheral micro-opioid receptor-mediated antinociceptive effect of fentanyl depends on activation of ATP-sensitive, but not other, K+ channels.</description><identifier>ISSN: 0100-879X</identifier><identifier>ISSN: 1414-431X</identifier><identifier>EISSN: 0100-879X</identifier><identifier>EISSN: 1414-431X</identifier><identifier>DOI: 10.1590/S0100-879X2005000100014</identifier><identifier>PMID: 15665994</identifier><language>eng</language><publisher>Brazil: Associação Brasileira de Divulgação Científica</publisher><subject>Analgesia ; Analgesics, Opioid - antagonists & inhibitors ; Analgesics, Opioid - pharmacology ; Animals ; BIOLOGY ; Carrageenan ; Dose-Response Relationship, Drug ; Fentanyl ; Fentanyl - antagonists & inhibitors ; Fentanyl - pharmacology ; Glibenclamide ; K+ channel ; Male ; MEDICINE, RESEARCH & EXPERIMENTAL ; Pain - chemically induced ; Pain - drug therapy ; Pain Measurement - drug effects ; Peripheral antinociception ; Potassium Channel Blockers - pharmacology ; Potassium Channels - drug effects ; Potassium Channels, Calcium-Activated ; Rats ; Rats, Wistar ; Receptors, Opioid, mu ; µ-Opioid receptor agonist</subject><ispartof>Brazilian journal of medical and biological research, 2005-01, Vol.38 (1), p.91-97</ispartof><rights>This work is licensed under a Creative Commons Attribution 4.0 International License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-3d6d9c2288cbb69d314dd1a556040fe6b53e8b7d5d2cddfa983471a935a6e0703</citedby><cites>FETCH-LOGICAL-c465t-3d6d9c2288cbb69d314dd1a556040fe6b53e8b7d5d2cddfa983471a935a6e0703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,24148,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15665994$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rodrigues, A R A</creatorcontrib><creatorcontrib>Castro, M S A</creatorcontrib><creatorcontrib>Francischi, J N</creatorcontrib><creatorcontrib>Perez, A C</creatorcontrib><creatorcontrib>Duarte, I D G</creatorcontrib><title>Participation of ATP-sensitive K+ channels in the peripheral antinociceptive effect of fentanyl in rats</title><title>Brazilian journal of medical and biological research</title><addtitle>Braz J Med Biol Res</addtitle><description>We examined the effect of several K+ channel blockers such as glibenclamide, tolbutamide, charybdotoxin (ChTX), apamin, tetraethylammonium chloride (TEA), 4-aminopyridine (4-AP), and cesium on the ability of fentanyl, a clinically used selective micro-opioid receptor agonist, to promote peripheral antinociception. Antinociception was measured by the paw pressure test in male Wistar rats weighing 180-250 g (N = 5 animals per group). Carrageenan (250 microg/paw) decreased the threshold of responsiveness to noxious pressure (delta = 188.1 +/- 5.3 g). This mechanical hyperalgesia was reduced by fentanyl (0.5, 1.5 and 3 microg/paw) in a peripherally mediated and dose-dependent fashion (17.3, 45.3 and 62.6%, respectively). The selective blockers of ATP-sensitive K+ channels glibenclamide (40, 80 and 160 microg/paw) and tolbutamide (80, 160 and 240 microg/paw) dose dependently antagonized the antinociception induced by fentanyl (1.5 microg/paw). In contrast, the effect of fentanyl was unaffected by the large conductance Ca2+-activated K+ channel blocker ChTX (2 microg/paw), the small conductance Ca2+-activated K+ channel blocker apamin (10 microg/paw), or the non-specific K+ channel blocker TEA (150 microg/paw), 4-AP (50 microg/paw), and cesium (250 microg/paw). These results extend previously reported data on the peripheral analgesic effect of morphine and fentanyl, suggesting for the first time that the peripheral micro-opioid receptor-mediated antinociceptive effect of fentanyl depends on activation of ATP-sensitive, but not other, K+ channels.</description><subject>Analgesia</subject><subject>Analgesics, Opioid - antagonists & inhibitors</subject><subject>Analgesics, Opioid - pharmacology</subject><subject>Animals</subject><subject>BIOLOGY</subject><subject>Carrageenan</subject><subject>Dose-Response Relationship, Drug</subject><subject>Fentanyl</subject><subject>Fentanyl - antagonists & inhibitors</subject><subject>Fentanyl - pharmacology</subject><subject>Glibenclamide</subject><subject>K+ channel</subject><subject>Male</subject><subject>MEDICINE, RESEARCH & EXPERIMENTAL</subject><subject>Pain - chemically induced</subject><subject>Pain - drug therapy</subject><subject>Pain Measurement - drug effects</subject><subject>Peripheral antinociception</subject><subject>Potassium Channel Blockers - pharmacology</subject><subject>Potassium Channels - drug effects</subject><subject>Potassium Channels, Calcium-Activated</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, Opioid, mu</subject><subject>µ-Opioid receptor agonist</subject><issn>0100-879X</issn><issn>1414-431X</issn><issn>0100-879X</issn><issn>1414-431X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kVtLHTEQgIMo9da_YPdd1k42yW7yKNKqVFCoBd9CNpl4cliTJYkF_73nIioU-pRkJt_HXAj5RuGMCgXffwMFaOWgHjoAAbB-AuU75OA9sfvpvk8OS1kCdAI4_UL2qeh7oRQ_II93Jtdgw2xqSLFJvjm_v2sLxhJq-IvNr9PGLkyMOJUmxKYusJkxh3mB2UyNiTXEZIPFefMbvUdb1xaPsZr4Mq2hbGo5JnveTAW_vp1H5M_PH_cXV-3N7eX1xflNa3kvastc75TtOintOPbKMcqdo0aIHjh47EfBUI6DE66zznmjJOMDNYoJ0yMMwI7I9dbrklnqOYcnk190MkFvAik_6k3DE2rBRyY4HaiynDMpJXqHHFHaYRAr2cp1tnUVG3BKepmec1wVrzfT1_9MfwUMW8DmVEpG_14ABb3e23_Iky05P49P6D64t0WxV6z2kW4</recordid><startdate>200501</startdate><enddate>200501</enddate><creator>Rodrigues, A R A</creator><creator>Castro, M S A</creator><creator>Francischi, J N</creator><creator>Perez, A C</creator><creator>Duarte, I D G</creator><general>Associação Brasileira de Divulgação Científica</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>GPN</scope><scope>DOA</scope></search><sort><creationdate>200501</creationdate><title>Participation of ATP-sensitive K+ channels in the peripheral antinociceptive effect of fentanyl in rats</title><author>Rodrigues, A R A ; Castro, M S A ; Francischi, J N ; Perez, A C ; Duarte, I D G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-3d6d9c2288cbb69d314dd1a556040fe6b53e8b7d5d2cddfa983471a935a6e0703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Analgesia</topic><topic>Analgesics, Opioid - antagonists & inhibitors</topic><topic>Analgesics, Opioid - pharmacology</topic><topic>Animals</topic><topic>BIOLOGY</topic><topic>Carrageenan</topic><topic>Dose-Response Relationship, Drug</topic><topic>Fentanyl</topic><topic>Fentanyl - antagonists & inhibitors</topic><topic>Fentanyl - pharmacology</topic><topic>Glibenclamide</topic><topic>K+ channel</topic><topic>Male</topic><topic>MEDICINE, RESEARCH & EXPERIMENTAL</topic><topic>Pain - chemically induced</topic><topic>Pain - drug therapy</topic><topic>Pain Measurement - drug effects</topic><topic>Peripheral antinociception</topic><topic>Potassium Channel Blockers - pharmacology</topic><topic>Potassium Channels - drug effects</topic><topic>Potassium Channels, Calcium-Activated</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, Opioid, mu</topic><topic>µ-Opioid receptor agonist</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rodrigues, A R A</creatorcontrib><creatorcontrib>Castro, M S A</creatorcontrib><creatorcontrib>Francischi, J N</creatorcontrib><creatorcontrib>Perez, A C</creatorcontrib><creatorcontrib>Duarte, I D G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>SciELO</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Brazilian journal of medical and biological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rodrigues, A R A</au><au>Castro, M S A</au><au>Francischi, J N</au><au>Perez, A C</au><au>Duarte, I D G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Participation of ATP-sensitive K+ channels in the peripheral antinociceptive effect of fentanyl in rats</atitle><jtitle>Brazilian journal of medical and biological research</jtitle><addtitle>Braz J Med Biol Res</addtitle><date>2005-01</date><risdate>2005</risdate><volume>38</volume><issue>1</issue><spage>91</spage><epage>97</epage><pages>91-97</pages><issn>0100-879X</issn><issn>1414-431X</issn><eissn>0100-879X</eissn><eissn>1414-431X</eissn><abstract>We examined the effect of several K+ channel blockers such as glibenclamide, tolbutamide, charybdotoxin (ChTX), apamin, tetraethylammonium chloride (TEA), 4-aminopyridine (4-AP), and cesium on the ability of fentanyl, a clinically used selective micro-opioid receptor agonist, to promote peripheral antinociception. Antinociception was measured by the paw pressure test in male Wistar rats weighing 180-250 g (N = 5 animals per group). Carrageenan (250 microg/paw) decreased the threshold of responsiveness to noxious pressure (delta = 188.1 +/- 5.3 g). This mechanical hyperalgesia was reduced by fentanyl (0.5, 1.5 and 3 microg/paw) in a peripherally mediated and dose-dependent fashion (17.3, 45.3 and 62.6%, respectively). The selective blockers of ATP-sensitive K+ channels glibenclamide (40, 80 and 160 microg/paw) and tolbutamide (80, 160 and 240 microg/paw) dose dependently antagonized the antinociception induced by fentanyl (1.5 microg/paw). In contrast, the effect of fentanyl was unaffected by the large conductance Ca2+-activated K+ channel blocker ChTX (2 microg/paw), the small conductance Ca2+-activated K+ channel blocker apamin (10 microg/paw), or the non-specific K+ channel blocker TEA (150 microg/paw), 4-AP (50 microg/paw), and cesium (250 microg/paw). These results extend previously reported data on the peripheral analgesic effect of morphine and fentanyl, suggesting for the first time that the peripheral micro-opioid receptor-mediated antinociceptive effect of fentanyl depends on activation of ATP-sensitive, but not other, K+ channels.</abstract><cop>Brazil</cop><pub>Associação Brasileira de Divulgação Científica</pub><pmid>15665994</pmid><doi>10.1590/S0100-879X2005000100014</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0100-879X |
ispartof | Brazilian journal of medical and biological research, 2005-01, Vol.38 (1), p.91-97 |
issn | 0100-879X 1414-431X 0100-879X 1414-431X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_54b3541719c443888efde4ee8c775e07 |
source | IngentaConnect Journals; SciELO |
subjects | Analgesia Analgesics, Opioid - antagonists & inhibitors Analgesics, Opioid - pharmacology Animals BIOLOGY Carrageenan Dose-Response Relationship, Drug Fentanyl Fentanyl - antagonists & inhibitors Fentanyl - pharmacology Glibenclamide K+ channel Male MEDICINE, RESEARCH & EXPERIMENTAL Pain - chemically induced Pain - drug therapy Pain Measurement - drug effects Peripheral antinociception Potassium Channel Blockers - pharmacology Potassium Channels - drug effects Potassium Channels, Calcium-Activated Rats Rats, Wistar Receptors, Opioid, mu µ-Opioid receptor agonist |
title | Participation of ATP-sensitive K+ channels in the peripheral antinociceptive effect of fentanyl in rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A52%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-scielo_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Participation%20of%20ATP-sensitive%20K+%20channels%20in%20the%20peripheral%20antinociceptive%20effect%20of%20fentanyl%20in%20rats&rft.jtitle=Brazilian%20journal%20of%20medical%20and%20biological%20research&rft.au=Rodrigues,%20A%20R%20A&rft.date=2005-01&rft.volume=38&rft.issue=1&rft.spage=91&rft.epage=97&rft.pages=91-97&rft.issn=0100-879X&rft.eissn=0100-879X&rft_id=info:doi/10.1590/S0100-879X2005000100014&rft_dat=%3Cscielo_doaj_%3ES0100_879X2005000100014%3C/scielo_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-3d6d9c2288cbb69d314dd1a556040fe6b53e8b7d5d2cddfa983471a935a6e0703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/15665994&rft_scielo_id=S0100_879X2005000100014&rfr_iscdi=true |